Dataset Information

Inhibition of lncRNA TMPO?AS1 suppresses proliferation, migration and invasion of colorectal cancer cells by targeting miR?143?3p.

ABSTRACT: Long non?coding RNAs (lncRNAs) are widely studied in cancer pathogenesis. Accumulating evidence has demonstrated that lncRNAs are involved in the cellular progression of colorectal cancer (CRC). However, the regulatory mechanism of lncRNA TMPO?antisense (AS)1 in CRC has not been fully elucidated. The present study aimed to elucidate the role and regulatory mechanisms of lncRNA TMPO?AS1 in CRC. In the present study, the expression levels of TMPO?AS1 and microRNA?143?3p (miR?143?3p) were detected using reverse transcription?quantitative PCR assay. The relative protein expression levels were measured via western blot analysis. MTT and Transwell assays were used to determine cell proliferation, migration and invasion, while a luciferase reporter assay was performed to assess the relationship between TMPO?AS1 and miR?143?3p. In addition, a tumor animal model was used to investigate the effect of TMPO?AS1 on tumor growth in CRC in vivo. TMPO?AS1 expression was increased and miR?143?3p expression was decreased in CRC cells. TMPO?AS1 knockdown and miR?143?3p overexpression significantly inhibited cell proliferation, migration and invasion of CRC cells. Luciferase reporter assay results demonstrated that miR?143?3p was a direct target of TMPO?AS1. Inhibition of miR?143?3p could alleviate the suppressive effects of TMPO?AS1 deletion on cell proliferation, migration and invasion of CRC cells. Furthermore, TMPO?AS1 deletion could inhibit tumor growth in CRC in vivo. It was concluded that TMPO?AS1 regulated cell proliferation, migration and invasion of CRC cells by targeting miR?143?3p. These findings provided a new regulatory network and therapeutic target for the treatment of CRC.

SUBMITTER: Zhao L

PROVIDER: S-EPMC7453500 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Inhibition of lncRNA TMPO‑AS1 suppresses proliferation, migration and invasion of colorectal cancer cells by targeting miR‑143‑3p.

Zhao Lei L Li Yu Y Song Ailin A

Molecular medicine reports 20200811 4

Long non‑coding RNAs (lncRNAs) are widely studied in cancer pathogenesis. Accumulating evidence has demonstrated that lncRNAs are involved in the cellular progression of colorectal cancer (CRC). However, the regulatory mechanism of lncRNA TMPO‑antisense (AS)1 in CRC has not been fully elucidated. The present study aimed to elucidate the role and regulatory mechanisms of lncRNA TMPO‑AS1 in CRC. In the present study, the expression levels of TMPO‑AS1 and microRNA‑143‑3p (miR‑143‑3p) were detected ...[more]

PMID: 32945436

Similar Datasets

Project description:Breast cancer is one of the most common malignant tumors in women, and causes a large number of cancer-related deaths. The main cause of death of breast cancer patients is tumor recurrence and metastasis. Recent studies show that lncRNA (Long non-coding RNA) plays an important role in breast cancer. However, the overall biological activity and clinical consequences of the lncRNA MIR17HG in breast cancer remain unclear. Thus, we investigate how the MIR17HG/miR-454-3p network impacts breast cancer cell proliferation and migration. Given the TCGA and Oncomine databases, the researchers evaluated variations in MIR17HG expression for the survival rates of breast cancer patients. The influence of MIR17HG on cell proliferation, migration, cell cycle, and the mRNA expression level of miR-454-3p and FAM135A (family with sequence similarity 135 member A) is identified. Luciferase assay was used to detect the regulatory effect of miR-454-3p on the 3'UTR region of FAM135A, and rescue experiments demonstrated that MIR17HG can up-regulate FAM135A expression by competitively binding miR-454-3p. The effect of FAM135A on the cloning and invasion of MCF-7 cells was detected. MIR17HG expression is reduced in breast cancer tissues, and patients with greater levels of MIR17HG expression have a better prognosis. MIR17HG overexpression caused G2/M arrest in breast cancer cells according to a flow cytometry assay. FAM135A knockdown enhances breast cancer cell proliferation and clone creation, as well as two-dimensional and three-dimensional migratory capacities. Patients with high FAM135A expression in their breast cancer had a better prognosis. These novel findings indicate that MIR17HG may be a potential target for breast cancer. Our findings demonstrated that MIR17HG might suppress breast cancer cell proliferation and migration by sponge miR-454-3p through ceRNA(competing endogenous RNAs) mechanism, indicating that targeting MIR17HG may be a feasible therapeutic candidate for breast cancer.

Dataset Information

Inhibition of lncRNA TMPO?AS1 suppresses proliferation, migration and invasion of colorectal cancer cells by targeting miR?143?3p.

Publications

Inhibition of lncRNA TMPO‑AS1 suppresses proliferation, migration and invasion of colorectal cancer cells by targeting miR‑143‑3p.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets